News for 'Indian Institute Of Health Management Research'

Delhi, Tamil Nadu revive fine for not wearing masks

Delhi, Tamil Nadu revive fine for not wearing masks

Rediff.com22 Apr 2022

Within three weeks of lifting its mask mandate, the Delhi government on Friday made masks mandatory at public places with immediate effect, and imposed a fine of Rs 500 for any violation as coronavirus cases rise in the city again.

Monkeypox: Experts allay fears, say disease less contagious and rarely fatal

Monkeypox: Experts allay fears, say disease less contagious and rarely fatal

Rediff.com24 Jul 2022

According to these experts, a monkeypox outbreak can effectively be tackled by strong surveillance.

Indian execs paying a high price for life in the fast lane

Indian execs paying a high price for life in the fast lane

Rediff.com17 Oct 2017

Experts say one in every four mental health problems is due to depression and anxiety at the workplace.

Cola brands get a health scare

Cola brands get a health scare

Rediff.com7 Apr 2016

Giants like Pepsi and Coke are fast losing shelf-space to healthier, functional options.

The 5 major drivers for Indian equities in 2021

The 5 major drivers for Indian equities in 2021

Rediff.com4 Jan 2021

The global COVID-19 situation, rollout of vaccines, geopolitical trends, Union Budget and economic recovery would be the major factors driving investor sentiments in 2021 after a tumultuous year which saw both 'the worst of times and the best of times' for the stock market, said analysts. What a year 2020 turned out to be! From witnessing gigantic losses to record-shattering gains, investors went on a roller-coaster ride amid the coronavirus pandemic and massive stimulus measures. Markets closed 2020 with remarkable gains of around 16 per cent, but will the winning ways continue in 2021 as well?

Budget 2018: What young India needs from Modi Sarkar

Budget 2018: What young India needs from Modi Sarkar

Rediff.com31 Jan 2018

Education, jobs, health and more: Experts share their wishlist.

1st uncrewed mission of Gaganyaan not possible in Dec: ISRO

1st uncrewed mission of Gaganyaan not possible in Dec: ISRO

Rediff.com26 Jul 2021

According to sources in the Bengaluru-headquartered space agency, under the Department of Space, delivery of hardware by the industry was hit due to the lockdown imposed in several States to contain the pandemic in recent months.

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

Economist Kalpana Kochhar to retire from IMF in July

Economist Kalpana Kochhar to retire from IMF in July

Rediff.com2 Jun 2021

Indian economist Kalpana Kochhar, who heads the Human Resources Department of the International Monetary Fund, is leaving the organisation to join the Bill and Melinda Gates Foundation, the IMF announced on Wednesday. Kochhar, who served in various senior positions during her three decades at the IMF, will retire on July 30, it said.

Remdesivir didn't cut mortality in Covid patients: WHO

Remdesivir didn't cut mortality in Covid patients: WHO

Rediff.com16 Oct 2020

The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.

Energy, health care sectors gain from Modi's UK visit

Energy, health care sectors gain from Modi's UK visit

Rediff.com15 Nov 2015

Prime Minister Narendra Modi's three-day visit to Britain has seen India and the UK agreeing on Rs 90,000 crore deals.

India better placed in fight against COVID-19: Modi

India better placed in fight against COVID-19: Modi

Rediff.com27 Jul 2020

Speaking after virtually launching COVID-19 testing facilities in Noida, Mumbai and Kolkata, Modi said that in the fight against coronavirus, India has come to a point where it does not lack in awareness, its scientific data is expanding and resources are also increasing.

'Most countries won't forgive deaths of children'

'Most countries won't forgive deaths of children'

Rediff.com22 Nov 2022

'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'

Test for TB if cough persists: Govt's revised Covid guidelines

Test for TB if cough persists: Govt's revised Covid guidelines

Rediff.com18 Jan 2022

Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Don't mock India's scientific past!

Don't mock India's scientific past!

Rediff.com27 Feb 2020

It is important to approach the belief of people in ancient India's achievements with a sense of proportion, balance and empathy, argues B S Raghavan, the distinguished civil servant.

How tech alumni plan to raise 21,000 crore to fight COVID-19

How tech alumni plan to raise 21,000 crore to fight COVID-19

Rediff.com2 Jul 2020

Over 5 million alumni from the Indian Institutes of Technology, Mumbai University and Institute of Chemical Technology, Mumbai, plan to raise Rs 21,000 crore to start the world's largest infection testing lab in Mumbai.

Community transmission of COVID-19 well-established: Experts

Community transmission of COVID-19 well-established: Experts

Rediff.com1 Jun 2020

"It is unrealistic to expect that COVID-19 pandemic can be eliminated at this stage given that community transmission is already well-established across large sections or sub-populations in the country," the report said.

Revealed: How India launched its war against COVID-19

Revealed: How India launched its war against COVID-19

Rediff.com30 Jul 2020

'The lockdown was for both: To flatten the curve or more correctly, delay the rapid spread of COVID outbreak, and to create healthcare infrastructure.'

96,000 vaccinators trained for world's largest immunisation exercise

96,000 vaccinators trained for world's largest immunisation exercise

Rediff.com1 Jan 2021

Of the 23.9 million vaccinators who provide vaccination under the universal immunisation programme, 15.4 million will be used for Covid vaccination.

Delhi gasps for breath: Govt orders 50% WFH, primary schools shut

Delhi gasps for breath: Govt orders 50% WFH, primary schools shut

Rediff.com4 Nov 2022

Delhi Chief Minister Arvind Kejriwal announced that primary schools will be closed from Saturday in view of spike in pollution levels in the national capital.

India's COVID-19 tally crosses 18-lakh mark

India's COVID-19 tally crosses 18-lakh mark

Rediff.com3 Aug 2020

This is the fifth consecutive day that COVID-19 cases have increased by more than 50,000 in the country.

Chinese investors are suddenly in love with Indian startups

Chinese investors are suddenly in love with Indian startups

Rediff.com2 Jan 2020

Not just from the likes of Alibaba and Didi Chuxing, Indian startups saw a surge in Chinese funding from financial investors in 2019. This is a seven-fold jump from $459 million in 2016.

$3 bn foreign investment in Indian stocks since Aug

$3 bn foreign investment in Indian stocks since Aug

Rediff.com26 Nov 2017

'The good news is that money continues to flow into India-focussed offshore funds.'

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

Eminent economist Isher Judge Ahluwalia passes away

Eminent economist Isher Judge Ahluwalia passes away

Rediff.com26 Sep 2020

Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.

Why we should be concerned about the Indian Army's future

Why we should be concerned about the Indian Army's future

Rediff.com2 Dec 2013

The army of the future needs a system of transparency and research. An open sociology of the army is a democratic necessity. An openness of information is a necessity of the army of the future fighting the next peace and next war on behalf of society, says social scientist Shiv Visvanathan.

Gita Gopinath to quit as IMF chief economist, return to Harvard

Gita Gopinath to quit as IMF chief economist, return to Harvard

Rediff.com20 Oct 2021

IMF's Chief Economist Gita Gopinath will leave her job in January next year and return to the prestigious Harvard University, according to the global financial institution.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

Record 28,472 COVID-19 patients recover in 24 hours

Record 28,472 COVID-19 patients recover in 24 hours

Rediff.com22 Jul 2020

India's COVID-19 recovery rate rose to 63.13 per cent on Wednesday with a record 28,472 patients recuperating from the disease in 24 hours, while the case fatality rate further dropped to 2.41 per cent, the Union health ministry said.

'If he was in India, Einstein wouldn't have got out of school'

'If he was in India, Einstein wouldn't have got out of school'

Rediff.com24 Mar 2023

'Most students find it difficult to cope with the way they are expected to learn at the IITs.' 'So, all the students face the same stress.' 'But those students who are mentally weak are more affected.'

30 municipal areas account for 79% of India's COVID caseload

30 municipal areas account for 79% of India's COVID caseload

Rediff.com15 May 2020

A total of 27,920 people have been cured of the disease with 1,685 in the last 24 hours, taking the recovery rate to 34.06 per cent, the ministry said.

This man will help Modi govt to transform Indian businesses

This man will help Modi govt to transform Indian businesses

Rediff.com23 Sep 2014

The former McKinsey India head is presently on board of many big Indian conglomerates.

4 lions at Singapore zoo test positive for COVID-19

4 lions at Singapore zoo test positive for COVID-19

Rediff.com10 Nov 2021

The country also reported 3,397 fresh COVID-19 cases, including 169 from dormitories for migrant workers.

Delhi Covid situation to come under control in 7-10 days: Kejriwal

Delhi Covid situation to come under control in 7-10 days: Kejriwal

Rediff.com13 Nov 2020

Pollution is biggest reason behind the spike in COVID-19 cases in Delhi. We had situation under control until October 20, the CM said.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

54 companies wait in the wings with IPOs worth Rs 1.4 trn

54 companies wait in the wings with IPOs worth Rs 1.4 trn

Rediff.com5 Apr 2022

Fundraising activity in the upcoming financial year 2022-23 may even surpass FY22 when 52 Indian companies raised a record Rs 1.11 trillion via initial public offerings (IPOs). According to a note by PRIME Database, 54 companies (including LIC) plan to raise Rs 1.4 trillion and currently hold the Securities and Exchange Board of India's (Sebi's) approval. Another 43 companies, the note said, are looking to raise about Rs 81,000 crore but waiting for Sebi nod.

Amartya Sen skeptical over PM Modi's idea of secularism

Amartya Sen skeptical over PM Modi's idea of secularism

Rediff.com7 Jul 2015

Nobel Laureate economist Amartya Sen on Tuesday expressed scepticism about Prime Minister Narendra Modi's idea of secularism, asserting he would like to see "more action" in reaching out to the minorities.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.